4 profiles of patients in whom it is worth to use of aripiprazole Review article
Article Sidebar
Published:
Jun 30, 2016
Keywords:
aripiprazol, schizophrenia, bipolar disorder
Main Article Content
Abstract
The paper presents descriptions of four patients with the diagnosis of schizophrenia and bipolar disorder treated with aripiprazole. Those clinical vignettes were paired with knowledge about specific profile of aripiprazole therapeutic action.
Article Details
How to Cite
Murawiec , S. (2016). 4 profiles of patients in whom it is worth to use of aripiprazole. Medycyna Faktow (J EBM), 9(2(31), 122-125. Retrieved from https://journalsmededu.pl/index.php/jebm/article/view/2247
Issue
Section
Articles
Copyright © by Medical Education. All rights reserved.
References
1. Bhattacharjee J., El-Sayeh H.G.: Aripiprazole versus typicals for schizophrenia. Cochrane Database Syst. Rev. 2008; (1): CD006617 [doi: 10.1002/14651858.CD006617.pub2].
2. Leucht S., Corves C., Arbter D. et al.: Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis. Lancet 2009; 373(9657): 31-41.
3. Khanna P., Komossa K., Rummel-Kluge C. et al.: Aripiprazole versus other atypical antipsychotics for schizophrenia. Cochrane Database Syst. Rev. 2013; 2: CD006569 [doi: 10.1002/14651858.CD006569.pub4].
4. Brown R., Taylor M.J., Geddes J.: Aripiprazole alone or in combination for acute mania. Cochrane Database Syst. Rev. 2013; 12: CD005000 [doi: 10.1002/14651858.CD005000.pub2].
5. Wang L.J., Ree S.C., Huang Y.S. et al.: Adjunctive effects of aripiprazole on metabolic profiles: comparison of patients treated with olanzapine to patients treated with other atypical antipsychotic drugs. Prog. Neuropsychopharmacol. Biol. Psychiatry 2013; 40: 260-266.
6. Keltner N.L.; Johnson V.: Biological perspectives. Aripiprazole: a third generation of antipsychotics begins? Perspect. Psychiatr. Care 2002; 38: 157-159.
7. Mailman R.B., Murthy V.: Third generation antipsychotic drugs: partial agonism or receptor functional selectivity? Curr. Pharm. Des. 2010; 16(5): 488-501.
8. McQuade R.D., Burris K.D., Jordan S. et al.: Aripiprazole: a dopamine-serotonin system stabilizer. Int. J. Neuropsychopharmacol. 2002; (supl. 5): S176.
9. Bandelow B., Meier A.: Aripiprazole, a “dopamine-serotonin system stabilizer” in the treatment of psychosis. German J. Psychiatry 2003; 6: 9-16.
10. Lacasse J.R., Leo J.: Questionable Advertising of Psychotropic Medications and Disease Mongering. PLoS Med. 2006; 3(7): e321.
2. Leucht S., Corves C., Arbter D. et al.: Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis. Lancet 2009; 373(9657): 31-41.
3. Khanna P., Komossa K., Rummel-Kluge C. et al.: Aripiprazole versus other atypical antipsychotics for schizophrenia. Cochrane Database Syst. Rev. 2013; 2: CD006569 [doi: 10.1002/14651858.CD006569.pub4].
4. Brown R., Taylor M.J., Geddes J.: Aripiprazole alone or in combination for acute mania. Cochrane Database Syst. Rev. 2013; 12: CD005000 [doi: 10.1002/14651858.CD005000.pub2].
5. Wang L.J., Ree S.C., Huang Y.S. et al.: Adjunctive effects of aripiprazole on metabolic profiles: comparison of patients treated with olanzapine to patients treated with other atypical antipsychotic drugs. Prog. Neuropsychopharmacol. Biol. Psychiatry 2013; 40: 260-266.
6. Keltner N.L.; Johnson V.: Biological perspectives. Aripiprazole: a third generation of antipsychotics begins? Perspect. Psychiatr. Care 2002; 38: 157-159.
7. Mailman R.B., Murthy V.: Third generation antipsychotic drugs: partial agonism or receptor functional selectivity? Curr. Pharm. Des. 2010; 16(5): 488-501.
8. McQuade R.D., Burris K.D., Jordan S. et al.: Aripiprazole: a dopamine-serotonin system stabilizer. Int. J. Neuropsychopharmacol. 2002; (supl. 5): S176.
9. Bandelow B., Meier A.: Aripiprazole, a “dopamine-serotonin system stabilizer” in the treatment of psychosis. German J. Psychiatry 2003; 6: 9-16.
10. Lacasse J.R., Leo J.: Questionable Advertising of Psychotropic Medications and Disease Mongering. PLoS Med. 2006; 3(7): e321.